EPISODE · Feb 5, 2026 · 17 MIN
Aflac Q4 2025 Financial Performance and 2026 Strategic Outlook
from Daily Market Download · host Daily Market Download
Aflac’s Q4 2025 results show Adjusted EPS rose to $1.57, though net earnings fell to $1.4 billion. While Japan sales surged 15.7% due to new cancer products, premiums there are declining. U.S. premiums grew 4%, supported by strong capital and $800 million in share repurchases.
What this episode covers
Aflac’s Q4 2025 results show Adjusted EPS rose to $1.57, though net earnings fell to $1.4 billion. While Japan sales surged 15.7% due to new cancer products, premiums there are declining. U.S. premiums grew 4%, supported by strong capital and $800 million in share repurchases.
NOW PLAYING
Aflac Q4 2025 Financial Performance and 2026 Strategic Outlook
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m